We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bioventix Plc | LSE:BVXP | London | Ordinary Share | GB00B4QVDF07 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-50.00 | -1.12% | 4,425.00 | 4,400.00 | 4,450.00 | 4,475.00 | 4,425.00 | 4,475.00 | 1,798 | 14:55:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 12.82M | 8.37M | 1.6071 | 27.53 | 230.51M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/3/2017 08:01 | Chinese buying product for R&D purposes. Trying to see how they can copy the technology I guess. Even with the resources that they can bring to bear, it will take them a little while I would have thought. | housemartin2 | |
27/3/2017 07:50 | Igbert - and the cost of sales fell! | trident5 | |
27/3/2017 07:36 | On Peter Harrison's commentary, "never has so little been said about so much". | boros10 | |
27/3/2017 07:26 | Well. There's your news on Vitamin D and a progressive dividend!Admin expenses went up by over £1000!!!Superbly run company: £20 soon.Thanks to the board and employees. | igbertsponk | |
23/3/2017 14:14 | But only 14 employees I believe. Incredible business model. | crazycoops | |
21/3/2017 15:37 | 4 directors ;-) | igbertsponk | |
21/3/2017 15:15 | 27th March is the results | sherylchan | |
21/3/2017 15:02 | And the management team is, like, 3 people.... | ilovefrogs | |
21/3/2017 14:52 | Yes. No doubt they will be tying the release into a board meeting. I doubt they have many as they're so well run. | igbertsponk | |
21/3/2017 14:33 | H1 results must be imminent? They were released on 21 March last year. | ilovefrogs | |
20/3/2017 15:00 | Won't stay down this share, which is nice. | igbertsponk | |
01/3/2017 18:41 | That would set this on fire but I have set my own expectations a little later in the year. Should be further guidance in or around results though (and I think what we are seeing is people buying in ahead of results). | crazycoops | |
01/3/2017 17:33 | Ooooh - let's hope so! | ilovefrogs | |
01/3/2017 17:09 | ilovefrogs - maybe there is, just not in the public domain yet....... | martinthebrave | |
01/3/2017 16:53 | ...but still no sign of the Siemens Troponin test launch. | ilovefrogs | |
01/3/2017 09:27 | Good innit - great company with such low admin expenses. Directors are stars. | igbertsponk | |
01/3/2017 09:12 | Heading for a MC of £100M+ with interim results due over the next two weeks! | a1samu | |
28/2/2017 17:00 | Nice inch up again. | igbertsponk | |
24/2/2017 11:40 | London Times today reports on a device called Vitalscan that can diagnose a heart attack in 5 mins by measuring the electro-magnetic fluctuations of the heart. Rules out a heart attack in 1/3 patients ultimately found to have no heart condition (means that it is 1/3 effective in patients with suspected heart attach ??)in earlier tests. Now being trialled in 4 NHS A&E depts. Kit costs £100k a pop - but that is now not if adopted I guess. Anyone know more about this ? How does this fit in with the troponin testing ? | housemartin2 | |
22/2/2017 12:12 | Too soon it seems ;-) | igbertsponk | |
13/2/2017 08:28 | I've sold out here today. Made 50% in a fairly short time period. | rcturner2 | |
05/2/2017 03:52 | Did not see this until searching for some data this weekend: Pages 49 & 50 are of interest to BVXP investors. | lauders | |
03/2/2017 10:13 | Let's hope this move to higher ground is sustainable. | soundsplausible | |
02/2/2017 13:12 | Must be presenting well! Nice ticks up this week. | igbertsponk |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions